Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases)

Blood

Volumn 90, Issue 8, 1997, Pages 3118-3129

  Los, Marek ^b   Herr, Ingrid ^b   Friesen, Claudia ^b   Fulda, Simone ^b   Schulze Osthoff, Klaus ^b   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; CYCLOHEXIMIDE; CYTARABINE; DOXORUBICIN; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; METHOTREXATE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; T CELL LEUKEMIA;

EID: 0030762122     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.3118     Document Type: Article

References (54)

1. Chabner BA, Myers CE: Clinical pharmacology of cancer chemotherapy, in deVita VTJ, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott, 1989, p 349
2. Barry MA, Behnke CA, Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthennia. Biochem Pharmacol 40:2353, 1990
3. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845, 1997
4. Sen S, D'Incalci M: Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307:122, 1992
5. Ling YH, Priebe W, Perez-Soler R: Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res 53:1845, 1993
6. Ellis RE, Yuan J, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 7:663, 1991
7. Kerr JFR, Winterford CM, Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 73:2013, 1994
8. Hengartner MO, Horvitz HR: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665, 1994
9. Yuan JY, Shaham S, Ledoux S, Ellis H, Horvitz HR: The C. elegans cell death gene ced 3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75:641, 1993
10. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner C, Black RA: Molecular cloning of the interleukin-1β converting enzyme. Science 256:97, 1992
11. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J: A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768, 1992
12. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J: Induction of apoptosis in fibroblasts by IL-1β converting enzyme, a mammalian homolog of the C. elegans cell death gene ced 3. Cell 75:653, 1993
13. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind, Rodman L, Salfeld J, Towne E, Tracey D, Ward well S, Wei FY, Wong W, Kamen R, Seshadri T: Mice deficient in IL-1β converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80:401, 1995
14. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000, 1995
15. Kumar S, Harvey NL: Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett 375:169, 1995
16. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/Ced-3 proteases nomenclature. Cell 87:171, 1996
17. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349, 1995
18. Schulze-Osthoff K, Bauer M, Vogt M, Los M: Role of ICE-related and other proteases in Fas-mediated apoptosis. Cell Death Diff 3:177, 1996
19. Fraser A, Evan G: A licence to kill. Cell 85:781, 1996
20. Walker NPC, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett CR, Hamill LD, Herzog L, Hugunin M, Houy M, Mankovich JA, McGuiness L, Orlewicz E, Paskind M, Pratt CA, Reis P, Summani A, Terravova M, Welch JP, Xiong L, Möller A, Tracey DE, Kamen R, Wong WW: Crystal structure of the cysteine protease interleukin-1β-converting enzyme: A (p20/p10)2 heterodimer. Cell 78:343, 1994
21. Wilson KP, Black R, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ: Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270, 1994
22. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
23. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32β, a mammalian homolog of Ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose)polymerase. Cell 81:801, 1995
24. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME, Debatin K-M: The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:175, 1994
25. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
26. Debatin K-M: Disturbance of the CD95 (APO-1/Fas) system in disorders of lymphohematopoetic cells. Cell Death Diff 3:185, 1996
27. Debatin K-M, Goldmann CK, Bamford R, Waldmann TA, Krammer PH: Monoclonal antibody-mediated apoptosis in adult T-cell leukemia. Lancet 335:497, 1990
28. Debatin K-M, Goldmann CK, Waldmann TA, Krammer PH: APO-1 induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81:2972, 1993
29. Lücking-Famira K-M, Daniel PT, Möller P, Krammer PH: Apo-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. Leukemia 8:1825, 1994
30. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
31. Los M, Van deCraen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Dröge W, Krammer PH, Fiers W, Schulze-Osthoff K: Requirement of an ICE/Ced-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81, 1995
32. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78, 1995
33. White K, Tahaoglu E, Steller H: Cell killing by the Drosophila gene reaper. Science 271:805, 1996
34. Pronk GJ, Ramer K, Amiri P, Williams LT: Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808, 1996
35. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995
36. Bellamy WT: P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 36:161, 1996
37. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539, 1994
38. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
39. Friesen C, Herr I, Krammer PH, Debatin K-M: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574, 1996
40. Trauth BC, Klas C, Peter AMJ, Matzku S, Möller P, Falk W, Debatin K-M, Krammer PH: Monoclonal antibody mediated tumor regression by induction of apoptosis. Science 245:301, 1989
41. Hardin JA, Sherr DH, DeMaria M, Lopez PA: A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation. J Immunol Methods 154:99, 1992
42. Pennington MW, Thornberry NA: Synthesis of a fluorogenic interleukin-1β converting enzyme substrate based on resonance energy transfer. Pept Res 7:72, 1994
43. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438, 1995
44. Datta R, Banach D, Kojima H, Talanian RV, Alnemri ES, Wong WW, Kufe DW: Activation of the CPP32 protease induced by 1-β-D-Arabinofuranosylcytosine and other DNA-damaging agents. Blood 88:1936, 1996
45. L overexpression inhibits taxol-induced Yama protease activity and apoptosis. Cell Growth Diff 7:1087, 1996
46. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogemous leukemia HL-60 cells. Cancer Res 56:4743, 1996
47. Boldin MP, Goncharov TM, Goltsev JT, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/ APO-1 and TNF receptor-induced cell death. Cell 85:803, 1996
48. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/Ced3-like protease, is recruited to the CD95 (Fas/ Apo-1) death-inducing signaling complex. Cell 85:817, 1996
49. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME: Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579, 1995
50. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82:405, 1995
51. Cifone MG, De Maria R, Roncaioli P, Camarda G, Santoni A, Ruberti G, Testi R: Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 14:5859, 1995
52. Gulbins E, Bissonette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D: FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341, 1995
53. Schroder CP, Godwin AK, O'Dwyer PJ, Tew KD, Hamilton TC, Ozols RF: Glutathione and drug resistance. Cancer Invest 14:158, 1996
54. Landowski TH, Gleason-Guzman MC, Dalton WS: Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 89:1854, 1997